REGULATION OF PROTEIN-TYROSINE PHOSPHATASES BY INSULIN AND INSULIN-LIKE GROWTH FACTOR-I

被引:0
|
作者
KENNER, KA
HILL, DE
OLEFSKY, JM
KUSARI, J
机构
[1] ONCOGENE SCI,CAMBRIDGE,MA 02142
[2] UNIV CALIF SAN DIEGO,DEPT MED,DIV ENDOCRINOL METAB,LA JOLLA,CA 92093
[3] VET ADM MED CTR,MED RES SERV,SAN DIEGO,CA 92161
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we have examined the effects of insulin and insulin-like growth factor (IGF)-I on protein tyrosine phosphatase (PTPase) activity in rat L6 skeletal muscle cells. Under basal conditions, about 85% of total cellular PTPase activity was associated with the particulate (Triton X-100-soluble) fraction. Incubation of the cells with 100 nm insulin or IGF-I significantly increased particulate PTPase activity (p < 0.005) without altering activity in the supernatant or Triton X-100-insoluble fractions. Dose response studies suggested that the effect of each hormone was mediated through its own receptor. PTPase activity was regulated by both acute and chronic insulin and IGF-I treatment. Maximal stimulation by both ligands occurred at 32 h and then declined. By using an antibody and a cDNA specific for PTPase1B, we found that the chronic stimulation of PTPase activity was accompanied by enhanced expression of PTPase1B mRNA and protein. Maximal induction of PTPase1B mRNA and protein by insulin and IGF-I occurred at 12 and 24 h, respectively. Based on these data, it can be suggested that ligand-stimulated PTPase activity might oppose tyrosine kinase-mediated insulin or IGF-I signal transmission and thus desensitize cells to long-term action by insulin and IGF-I. However, it is also possible that PTPases act as positive mediators of insulin and IGF-I action.
引用
收藏
页码:25455 / 25462
页数:8
相关论文
共 50 条
  • [21] Insulin-like growth factor-I deficiency
    Camacho-Hübner, C
    Savage, M
    [J]. HORMONE RESEARCH, 2001, 55 : 17 - 20
  • [22] INSULIN-LIKE GROWTH FACTOR-I IN THE DOG
    EIGENMANN, JE
    [J]. FRONTIERS OF HORMONE RESEARCH, 1987, 17 : 161 - 172
  • [23] INSULIN-LIKE GROWTH FACTOR-I AND ERYTHROPOIESIS
    ARON, DC
    [J]. BIOFACTORS, 1992, 3 (04) : 211 - 216
  • [24] PURIFICATION OF INSULIN-LIKE GROWTH FACTOR-I
    MORRELL, DJ
    HOLDER, AT
    TAYLOR, AM
    HILL, D
    PULLEN, L
    PREECE, MA
    [J]. REGULATORY PEPTIDES, 1984, 9 (04) : 340 - 340
  • [25] Insulin-like growth factor-I resistance
    Jain, S
    Golde, DW
    Bailey, R
    Geffner, ME
    [J]. ENDOCRINE REVIEWS, 1998, 19 (05) : 625 - 646
  • [26] ALTERED REGULATION OF RENIN SECRETION BY INSULIN AND INSULIN-LIKE GROWTH FACTOR-I IN DIABETES
    JOSTVU, E
    HORTON, R
    ANTONIPILLAI, I
    [J]. CLINICAL RESEARCH, 1991, 39 (01): : A7 - A7
  • [27] REGULATION OF HEPATIC MESSENGER-RNA EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I AND FETAL INSULIN-LIKE GROWTH FACTOR-I BINDING-PROTEIN INVIVO AND INVITRO
    BONISCHNETZLER, M
    BINZ, K
    MARY, JL
    SCHMID, C
    SCHWANDER, J
    FROESCH, ER
    [J]. DIABETOLOGIA, 1989, 32 (07) : A470 - A470
  • [28] Insulin-like Growth Factor-I in Growth and Metabolism
    Backeljauw, P.
    Bang, P.
    Dunger, D. B.
    Juul, A.
    Le Bouc, Y.
    Rosenfeld, R.
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2010, 23 (1-2): : 3 - 16
  • [29] Impaired sensitivity to insulin and insulin-like growth factor-I in insulin-like growth factor binding protein-3 transgenic mice
    Silha, JV
    Gui, Y
    Murphy, LJ
    [J]. DIABETOLOGIA, 2002, 45 : A31 - A31
  • [30] Regulation of adult olfactory neurogenesis by insulin-like growth factor-I
    McCurdy, RD
    Féron, F
    McGrath, JJ
    Mackay-Sim, A
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (07) : 1581 - 1588